4 terminated, 1 completed. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow ApcinteX Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial SerpinPC - Hemophilia a, Hemophilia B | Phase 3 | Terminated | ApcinteX Ltd | 15 | 2024-07-11 | 2025-02-10 |
| A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors SerpinPC - Hemophilia B with Inhibitor, Hemophilia B | Phase 2 | Terminated | ApcinteX Ltd | 3 | 2023-07-28 | 2025-03-11 |
| The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B SerpinPC - Hemophilia a, Hemophilia B | Phase 2 | Terminated | ApcinteX Ltd | 60 | 2023-07-06 | 2025-03-11 |
| Hemophilia Non-Interventional Study Prior to SerpinPC Intervention (PRESent-5) No Intervention - Hemophilia a, Hemophilia B | Terminated | ApcinteX Ltd | 108 | 2022-12-09 | 2025-02-07 | |
| The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B) SerpinPC, Placebo - Hemophilia a, Hemophilia B | Phase 1 / Phase 2 | Completed | ApcinteX Ltd | 39 | 2019-08-14 | 2025-02-06 |
Hemophilia A (5) · Hemophilia B (5)
Protein C (3)
United Kingdom (4) · Armenia (3) · Australia (3) · France (3) · Germany (3) · India (3) · Italy (3) · Spain (3) · Taiwan (3) · Turkey (Türkiye) (3) · United States (3) · Canada (2) · Georgia (2) · Moldova (2) · Poland (2)
2023 (1)